Expression Database

GUDMAP:8934
Data Source
   
Gene
Cxxc4   CXXC finger 4
   
Theiler Stage TS21
   
Tissue female reproductive system
   
Images
Ovary mesonephros ventral side
Ovary mesonephros dorsal side
Global view of specimen ventral side
   
Whole-mount in situ hybridization is subject to technical limitations that may influence accuracy of the data (more info).
 
Submitters
Principal Investigator(s): Melissa H Little, University of Queensland, Brisbane, Australia, m.little@imb.uq.edu.au
Authors: Sean Grimmond, Darrin Taylor, Han Sheng Chiu, Kylie Georgas, Melissa Little, Rathi Thiagarajan, Emmanuelle Lesieur, Bree Rumballe
Submitted By: Kylie Georgas, University of Queensland, Brisbane, Australia, k.georgas@imb.uq.edu.au
Archive ID: 99
Submission ID: ml_251007_6575
   
Expression Mapping

Expression Strengths Key:
Present (unspecified strength)
Present (strong)
Present (moderate)
Present (weak)
Uncertain
Not Detected
   
Expression Patterns Key:
Homogeneous
Graded
Regional
Spotted
Ubiquitous
Restricted
Single cell
Contains note
View annotated components as a list Show annotation under groups information
Javascript Tree Menu  
   
Probe
Gene:
Symbol: Cxxc4
Name: CXXC finger 4 (MGI:2442112)
Probe ID: MGI:2408970 (maprobe:4714)
Name of cDNA: RIKEN clone A830026K07
Sequence ID:
AK043734.1
5' primer sequence: AAACACAGAGGCCCACTCAC
3' primer sequence: CGATGTTAATACGACTCACTATAGGGAACGGAGTACACTTGGTGGC
5' primer location: 76
3' primer location: 656
Origin of Clone used to make the Probe:
Strain:
  Tissue:
Probe Type: RNA
Type: antisense
Labelled with: digoxigenin
Visualisation method: alkaline phosphatase + NBT/BCIP
Lab Probe ID: 1784
   
Specimen
Theiler Stage: TS21
Other Staging System:
Tissue: female reproductive system
Strain: CD1
Genotype: Wild type
Sex: female
Specimen Preparation:
wholemount
Fixation Method: 4% paraformaldehyde
Experiment Notes:
Female urogenital tract removed and reproductive tissues examined. 1 specimen examined. WISH280807 1784 Colour development for 220min. Control probes Wnt4 and Shh colour developed for 85min and 1260min (21hr) respectively on TS20 whole urogenital tract.
  
Linked Publications
   
Linked Submissions
   
Acknowledgements

 

Disclaimer: Please note that the development of the GUDMAP website is an on-going process. Whilst we make every effort to ensure the quality of the information on these pages, the content cannot always be guaranteed to be accurate or complete. In addition, at certain times some functions may be restricted.
Department of Health and Human Services National Institutes of Health Contacts Citing GUDMAP National Institute of Diabetes and National Institute of Child Health and Human Development